Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lazaro E Aira

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Investigative Dermatology|June 25, 2019
B Cells and Melanoma PathogenesisLazaro E Aira, Gudrun F Debes
Current Drug Targets|February 5, 2016
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and ItolizumabPatricia Hernández, Ernesto Moreno, Lazaro E Aira, et al.
Mabs|October 16, 2015
Immunological evaluation of rheumatoid arthritis patients treated with itolizumabLazaro E Aira, Patricia Hernández, Dinorah Prada, et al.
Mabs|March 6, 2014
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabLazaro E Aira, Alejandro López-Requena, Dasha Fuentes, et al.
Oncogene|February 3, 2018
The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of BimLazaro E Aira, Elodie Villa, Pascal Colosetti, et al.
Frontiers in Pharmacology|May 26, 2017
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study TrialIraida Caballero, Lazaro E Aira, Anabel Lavastida, et al.
Cell Metabolism|March 20, 2018
Low-Protein Diet Induces IRE1α-Dependent Anticancer ImmunosurveillanceCamila Rubio-Patiño, Jozef P Bossowski, Gian Marco De Donatis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Investigative Dermatology|June 25, 2019
B Cells and Melanoma PathogenesisLazaro E Aira, Gudrun F Debes
Current Drug Targets|February 5, 2016
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and ItolizumabPatricia Hernández, Ernesto Moreno, Lazaro E Aira, et al.
Mabs|October 16, 2015
Immunological evaluation of rheumatoid arthritis patients treated with itolizumabLazaro E Aira, Patricia Hernández, Dinorah Prada, et al.
Mabs|March 6, 2014
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabLazaro E Aira, Alejandro López-Requena, Dasha Fuentes, et al.
Oncogene|February 3, 2018
The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of BimLazaro E Aira, Elodie Villa, Pascal Colosetti, et al.
Frontiers in Pharmacology|May 26, 2017
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study TrialIraida Caballero, Lazaro E Aira, Anabel Lavastida, et al.
Cell Metabolism|March 20, 2018
Low-Protein Diet Induces IRE1α-Dependent Anticancer ImmunosurveillanceCamila Rubio-Patiño, Jozef P Bossowski, Gian Marco De Donatis, et al.
Pageof 1